ArticleTranslational cancer research2022

Granzyme B for predicting the durable clinical benefit of anti-PD-1/PD-L1 immunotherapy in patients with non-small cell lung cancer.

Jae Heun Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.